Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of Group A and C Meningococcal Conjugate Vaccine in 3–5-Month-Old Infants
CTR20210868Phase 3Completed
- Sponsor
- Zhifei Biological
- Start
- Sep 2021
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal A+C conjugate vaccine in meningococcal disease, sponsored by Zhifei Biological. Started Sep 2021; status: completed.
02
Drugs
meningococcal A+C conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on CTR20210868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210868.